BIOR
Biora Therapeutics, Inc.
Set alert
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.22
- Prev close
- 0.22
- Mkt cap
- 2.04M
- Vol
- 169.45K
- Avg vol
- 132.00K
- EPS
- 0.36
- P/E
- 1.25
- Div yield
- 0.00%
More statistics
- Low
- 0.22
- High
- 0.22
- Forward P/E
- -0.04
- Beta
- 0.00
- Short ratio
- 2.37
- Inst. own
- 36.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 2.44
- 200-d avg
- 5.90
- 1y target
- 34.00
Discussion (14)
Sign in to join the discussion
VICKY HANUKA BIOR 3 years ago #3Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics' Royalty on Evrysdi
-- Royalty Pharma purchases a portion of royalties on Roche's Evrysdi for
$1.0 billion upfront
-- PTC Therapeutics has option to sell rest of royalty for up to $500
million; Royalty Pharma has option to buy half of rest of royalty for up
to $250 million
-- Transaction expected to enhance long-term Adjusted Cash Receipts growth
(non-GAAP)
-- Royalty Pharma to host conference call today, Thursday, October 19 at
9:00am EDT
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) announced today an agreement with PTC Therapeutics, Inc. to acquire additional royalties on Roche's Evrysdi for $1.0 billion upfront. The agreement includes options for PTC to sell up to all of its retained royalties on Evrysdi for up to $500 million or for Royalty Pharma to acquire half of such retained royalties for up to $250 million at a later date.
Cassieslawnservices boyle5 BIOR 3 years ago #4$BI0R..?????
Sidorovic BIOR 3 years ago #5Gradoth — you imminent SOB
Chris Richard BIOR 4 years ago #6Wow look at the volume at 1pm?! 400k…. Big buyer?
Chris Richard BIOR 4 years ago #7Wow. The FUD! Trying hard here!!
Chris Richard BIOR 4 years ago #8$BIOR whoa! Type 2 diabetes treatment. That’s a much bigger population than Crone’s.
Rollin, rollin, rollin… keep them doggies rollin….
Time for loser trust funders to eat a fat one